查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1539395

临床前影像市场：2024-2031年全球产业分析、规模、占有率、成长、趋势、预测

Preclinical Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 170 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球临床前影像市场的综合报告。本报告对重要的市场动态进行了详细评估，包括关键驱动因素、趋势、机会和挑战，并对市场结构提供了深入的见解。

关键见解

  • 临床前影像市场规模（2024年）：43亿美元
  • 预测市场规模（2031年）：59.6亿美元
  • 全球市场成长率（2024-2031年年复合成长率）：4.55%

临床前影像市场 - 报告范围：

临床前影像对于新药和新疗法的开发非常重要，它使研究人员能够在早期阶段可视化并了解干预措施的效果。临床前影像市场包括各种影像技术，如 MRI、PET、CT 和光学影像系统。这些技术应用于各种研究环境，包括学术机构、製药公司和合约研究组织（CRO），以支持药物开发、疾病研究和治疗功效研究。

研究中对先进成像技术的需求不断成长、药物发现投资的增加以及提高成像分辨率和精度的技术进步推动了市场成长。此外，慢性病的流行和个人化医疗需求的不断成长进一步推动了市场的扩张。

推动市场成长的因素：

有几个关键因素推动全球临床前影像市场。影像技术的快速进步，例如高解析度 MRI 和 PET/CT 系统的集成，大幅提高了研究能力。製药和生物技术公司对研发的投资不断增加，推动了对先进成像解决方案的需求，以加速药物开发进程。此外，慢性病的增加和个人化医疗的需求推动先进影像技术的采用，以实现准确的疾病建模和治疗评估。

分子影像和多模态成像系统的开发等技术创新也促进了市场成长。这些创新提高了临床前研究的精确度，能够对生物过程进行更详细的分析，并支持新疗法和疗法的进步。

市场限制因素：

儘管成长前景广阔，但临床前影像市场仍面临一些挑战。先进成像系统的高成本可能会限制其采用，特别是在发展中地区的小型研究机构或研发机构。此外，影像技术的复杂性和专业训练的需要可能会对有效利用造成障碍。新成像技术的监管限制和漫长的审批流程也可能影响市场动态。

应对这些挑战需要持续努力降低成本、加强用户培训并简化监管途径，以促进更广泛地获得先进成像解决方案。

市场机会：

由于技术进步和研究活动的增加，临床前影像市场提供了巨大的成长机会。携带式、经济高效的成像解决方案的开发以及人工智慧和机器学习资料分析的集成为市场扩张提供了新的途径。此外，研究机构、技术开发商和製药公司之间的合作预计将促进创新并加速先进成像技术的采用。

对个人化医疗和标靶治疗的日益关注也增加了开发适合特定研究需求的专门影像处理系统的机会。策略合作伙伴关係、对尖端技术的投资以及向新兴市场的扩张对于利用这些机会和维持市场成长非常重要。

本报告解决的关键问题

  • 推动全球临床前影像市场成长的关键因素是什么？
  • 哪些影像技术和应用在临床前研究中受到关注？
  • 技术进步如何改变临床前影像市场的竞争格局？
  • 谁是对临床前影像市场做出贡献的主要公司？
  • 全球临床前影像市场的新趋势和未来前景是什么？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围与定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 课题
    • 主要趋势
  • 临床前影像市场：价值链
    • 主要参与者名单
    • 主要经销商名单
  • 预测因子 - 相关性和影响
  • 新冠肺炎（COVID-19）影响评估
  • PESTLE分析
  • 波特五力分析

第3章 主要法规/标准

第4章 2019-2031年价格趋势分析

  • 影响价格的主要因素
  • 价格：依来源

第5章 全球临床前影像市场展望：实绩（2019-2023年）与预测（2024-2031年）

  • 市场规模（十亿美元）分析与预测
    • 过去的市场规模分析，2019-2023年
    • 目前市场规模预测，2024年至2031年
  • 全球临床前影像市场展望：产品类型
    • 2019-2023年历史市场规模（十亿美元）分析，依产品类型
    • 2024-2031年目前市场规模（十亿美元）预测，依产品类型
    • 市场吸引力分析：产品类型
  • 全球临床前影像市场展望：应用
    • 2019-2023年过去的市场规模（十亿美元）分析，依应用
    • 2024-2031年当前市场规模（十亿美元）预测，依应用
    • 市场吸引力分析：应用
  • 全球临床前影像市场展望：最终用户
    • 2019-2023年历史市场规模（十亿美元）分析，依最终用户
    • 2024-2031年目前市场规模（十亿美元）预测，依最终用户
    • 市场吸引力分析：最终用户

第6章 全球临床前影像市场展望：地区

  • 2019-2023年历史市场规模（十亿美元）分析，依地区
  • 2024-2031年当前市场规模（十亿美元）预测，依地区
    • 北美
    • 欧洲
    • 东亚
    • 南亚/大洋洲
    • 拉丁美洲
    • 中东、非洲
  • 市场吸引力分析：地区

第7章 北美临床前影像市场展望：实绩（2019-2023年）与预测（2024-2031年）

第8章 欧洲临床前影像市场展望：实绩（2019-2023年）与预测（2024-2031年）

第9章 东亚临床前影像市场展望：实绩（2019-2023年）与预测（2024-2031年）

第10章 南亚/大洋洲临床前影像市场展望：实绩（2019-2023年）与预测（2024-2031年）

第11章 拉丁美洲临床前影像市场展望：实绩（2019-2023年）与预测（2024-2031年）

第12章 中东和非洲的临床前影像展望：实绩（2019-2023年）和预测（2024-2031年）

第13章 竞争态势

  • 2024年市占率分析
  • 市场结构
    • 竞争强度图：依市场划分
    • 竞争仪表板
    • 层次结构分析
    • 区域分布分析
  • 公司简介（详细资料 - 概述、财务状况、策略、近期发展）
    • Bruker Corporation
    • Siemens AG
    • General Electric（GE）
    • TriFoil Imaging
    • PerkinElmer, Inc.
    • VisualSonics Inc.（Fujifilm）
    • Mediso Ltd.
    • Agilent Technologies
    • MILabs BV
    • MR Solutions
    • Molecubes

第14章 附录

  • 调查方法
  • 调查的先决条件
  • 首字母缩写词和缩写词
简介目录
Product Code: PMRREP34717

Persistence Market Research has recently released a comprehensive report on the global preclinical imaging market. This report provides an in-depth evaluation of essential market dynamics, including key drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

  • Preclinical Imaging Market Size (2024E): US$4.3 Bn
  • Projected Market Value (2031F): US$5.96 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 4.55%

Preclinical Imaging Market - Report Scope:

Preclinical imaging is pivotal in the development of new drugs and therapies, allowing researchers to visualize and understand the effects of interventions at an early stage. The preclinical imaging market encompasses a range of imaging technologies, including MRI, PET, CT, and optical imaging systems. These technologies are employed in various research settings, including academic institutions, pharmaceutical companies, and contract research organizations (CROs), to support drug development, disease research, and therapeutic efficacy studies.

Market growth is driven by the increasing demand for advanced imaging techniques in research, rising investments in drug discovery, and technological advancements that enhance imaging resolution and accuracy. Additionally, the growing prevalence of chronic diseases and the need for personalized medicine further propel market expansion.

Market Growth Drivers:

Several key factors are driving the global preclinical imaging market. The rapid evolution of imaging technologies, such as the integration of high-resolution MRI and PET/CT systems, is significantly enhancing research capabilities. Increased investment in R&D by pharmaceutical and biotechnology companies is fueling demand for sophisticated imaging solutions to accelerate drug development processes. Moreover, the rise in chronic diseases and the need for personalized medicine are driving the adoption of advanced imaging technologies for precise disease modeling and therapeutic assessments.

Technological innovations, including advancements in molecular imaging and the development of multimodal imaging systems, are also contributing to market growth. These innovations improve the accuracy of preclinical studies and enable more detailed analysis of biological processes, supporting the advancement of new treatments and therapies.

Market Restraints:

Despite promising growth prospects, the preclinical imaging market faces several challenges. The high cost associated with advanced imaging systems can limit their adoption, particularly among smaller research institutions and organizations in developing regions. Additionally, the complexity of imaging technologies and the need for specialized training can pose barriers to effective utilization. Regulatory constraints and the lengthy approval processes for new imaging technologies may also impact market dynamics.

Addressing these challenges requires ongoing efforts to reduce costs, enhance user training, and streamline regulatory pathways to facilitate broader access to advanced imaging solutions.

Market Opportunities:

The preclinical imaging market presents significant growth opportunities driven by technological advancements and increasing research activities. The development of portable and cost-effective imaging solutions, as well as the integration of AI and machine learning for data analysis, offers new avenues for market expansion. Furthermore, collaborations between research institutions, technology developers, and pharmaceutical companies are expected to drive innovation and accelerate the adoption of advanced imaging technologies.

The growing focus on personalized medicine and targeted therapies also opens up opportunities for the development of specialized imaging systems tailored to specific research needs. Strategic partnerships, investment in cutting-edge technologies, and expansion into emerging markets will be crucial for capitalizing on these opportunities and sustaining market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the preclinical imaging market globally?
  • Which imaging technologies and applications are gaining traction in preclinical research?
  • How are technological advancements reshaping the competitive landscape of the preclinical imaging market?
  • Who are the key players contributing to the preclinical imaging market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global preclinical imaging market?

Competitive Intelligence and Business Strategy:

Leading players in the global preclinical imaging market, including Siemens Healthineers, GE Healthcare, and Bruker Corporation, are focusing on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced imaging systems, such as high-resolution MRI and PET/CT scanners, and integrate cutting-edge technologies like AI for enhanced imaging capabilities. Collaborations with research institutions, pharmaceutical companies, and CROs facilitate market access and promote technology adoption. Emphasis on clinical research, evidence-based practices, and user training is essential for driving market growth and advancing preclinical imaging capabilities.

Key Companies Profiled:

  • Bruker Corporation
  • Siemens A.G.
  • General Electric (GE)
  • TriFoil Imaging
  • PerkinElmer, Inc.
  • VisualSonics Inc. (Fujifilm)
  • Mediso Ltd.
  • Agilent Technologies
  • MILabs B.V.
  • MR Solutions
  • Molecubes

Preclinical Imaging Market Research Segmentation

By Product Type

  • Imaging Systems
  • Reagents

By Application

  • Research and Development
  • Drug Discovery

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic and research centres
  • Imaging Centres

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Preclinical Imaging Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Industry Developments and Key Market Events
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Preclinical Imaging Market: Value Chain
    • 2.3.1. List of key players
    • 2.3.2. List of key distributors
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. Covid-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter Five Force's Analysis

3. Key Regulations/ Standards

4. Price Trend Analysis, 2019-2031

  • 4.1. Key Factors Impacting Prices
  • 4.2. Prices by Source

5. Global Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Market Size (US$ Bn) Analysis and Forecast
    • 5.1.1. Historical Market Size Analysis, 2019-2023
    • 5.1.2. Current Market Size Forecast, 2024-2031
  • 5.2. Global Preclinical Imaging Market Outlook: Product Type
    • 5.2.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 5.2.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 5.2.2.1. Imaging Systems
        • 5.2.2.1.1. Optical Imaging Systems
        • 5.2.2.1.2. Nuclear Imaging Systems
        • 5.2.2.1.3. Micro MRI Systems
        • 5.2.2.1.4. Micro Ultrasound Systems
        • 5.2.2.1.5. Micro CT Systems
        • 5.2.2.1.6. Photoacoustic Imaging Systems
        • 5.2.2.1.7. Magnetic Particle Imaging Systems
      • 5.2.2.2. Reagents
        • 5.2.2.2.1. Preclinical Optical Imaging Reagents
        • 5.2.2.2.2. Preclinical Nuclear Imaging Reagents
        • 5.2.2.2.3. Preclinical MRI Contrast Agents
        • 5.2.2.2.4. Preclinical CT Contrast Agents
        • 5.2.2.2.5. Software
    • 5.2.3. Market Attractiveness Analysis: Product Type
  • 5.3. Global Preclinical Imaging Market Outlook: Application
    • 5.3.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 5.3.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 5.3.2.1. Research and Development
      • 5.3.2.2. Drug Discovery
    • 5.3.3. Market Attractiveness Analysis: Application
  • 5.4. Global Preclinical Imaging Market Outlook: End-user
    • 5.4.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 5.4.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 5.4.2.1. Pharmaceutical & Biotechnology Companies
      • 5.4.2.2. Academic and research centres
      • 5.4.2.3. Imaging Centres
      • 5.4.2.4. Other End-users
    • 5.4.3. Market Attractiveness Analysis: End-user

6. Global Preclinical Imaging Market Outlook: Region

  • 6.1. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 6.2. Current Market Size (US$ Bn) Forecast By Region, 2024-2031
    • 6.2.1. North America
    • 6.2.2. Europe
    • 6.2.3. East Asia
    • 6.2.4. South Asia and Oceania
    • 6.2.5. Latin America
    • 6.2.6. Middle East & Africa
  • 6.3. Market Attractiveness Analysis: Region

7. North America Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 7.1.1. By Country
    • 7.1.2. By Product Type
    • 7.1.3. By Application
    • 7.1.4. By End-user
  • 7.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. North America Preclinical Imaging Market Outlook: Product Type
    • 7.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 7.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 7.3.2.1. Imaging Systems
        • 7.3.2.1.1. Optical Imaging Systems
        • 7.3.2.1.2. Nuclear Imaging Systems
        • 7.3.2.1.3. Micro MRI Systems
        • 7.3.2.1.4. Micro Ultrasound Systems
        • 7.3.2.1.5. Micro CT Systems
        • 7.3.2.1.6. Photoacoustic Imaging Systems
        • 7.3.2.1.7. Magnetic Particle Imaging Systems
      • 7.3.2.2. Reagents
        • 7.3.2.2.1. Preclinical Optical Imaging Reagents
        • 7.3.2.2.2. Preclinical Nuclear Imaging Reagents
        • 7.3.2.2.3. Preclinical MRI Contrast Agents
        • 7.3.2.2.4. Preclinical CT Contrast Agents
        • 7.3.2.2.5. Software
  • 7.4. North America Preclinical Imaging Market Outlook: Application
    • 7.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 7.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 7.4.2.1. Research and Development
      • 7.4.2.2. Drug Discovery
  • 7.5. North America Preclinical Imaging Market Outlook: End-user
    • 7.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 7.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 7.5.2.1. Pharmaceutical & Biotechnology Companies
      • 7.5.2.2. Academic and research centres
      • 7.5.2.3. Imaging Centres
      • 7.5.2.4. Other End-users
  • 7.6. Market Attractiveness Analysis

8. Europe Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 8.1.1. By Country
    • 8.1.2. By Product Type
    • 8.1.3. By Application
    • 8.1.4. By End-user
  • 8.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 8.2.1. Germany
    • 8.2.2. France
    • 8.2.3. U.K.
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Russia
  • 8.3. Europe Preclinical Imaging Market Outlook: Product Type
    • 8.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 8.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 8.3.2.1. Imaging Systems
        • 8.3.2.1.1. Optical Imaging Systems
        • 8.3.2.1.2. Nuclear Imaging Systems
        • 8.3.2.1.3. Micro MRI Systems
        • 8.3.2.1.4. Micro Ultrasound Systems
        • 8.3.2.1.5. Micro CT Systems
        • 8.3.2.1.6. Photoacoustic Imaging Systems
        • 8.3.2.1.7. Magnetic Particle Imaging Systems
      • 8.3.2.2. Reagents
        • 8.3.2.2.1. Preclinical Optical Imaging Reagents
        • 8.3.2.2.2. Preclinical Nuclear Imaging Reagents
        • 8.3.2.2.3. Preclinical MRI Contrast Agents
        • 8.3.2.2.4. Preclinical CT Contrast Agents
        • 8.3.2.2.5. Software
  • 8.4. Europe Preclinical Imaging Market Outlook: Application
    • 8.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 8.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 8.4.2.1. Research and Development
      • 8.4.2.2. Drug Discovery
  • 8.5. Europe Preclinical Imaging Market Outlook: End-user
    • 8.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 8.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 8.5.2.1. Pharmaceutical & Biotechnology Companies
      • 8.5.2.2. Academic and research centres
      • 8.5.2.3. Imaging Centres
      • 8.5.2.4. Other End-users
  • 8.6. Market Attractiveness Analysis

9. East Asia Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 9.1.1. By Country
    • 9.1.2. By Product Type
    • 9.1.3. By Application
    • 9.1.4. By End-user
  • 9.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 9.2.1. China
    • 9.2.2. Japan
    • 9.2.3. South Korea
  • 9.3. East Asia Preclinical Imaging Market Outlook: Product Type
    • 9.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 9.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 9.3.2.1. Imaging Systems
        • 9.3.2.1.1. Optical Imaging Systems
        • 9.3.2.1.2. Nuclear Imaging Systems
        • 9.3.2.1.3. Micro MRI Systems
        • 9.3.2.1.4. Micro Ultrasound Systems
        • 9.3.2.1.5. Micro CT Systems
        • 9.3.2.1.6. Photoacoustic Imaging Systems
        • 9.3.2.1.7. Magnetic Particle Imaging Systems
      • 9.3.2.2. Reagents
        • 9.3.2.2.1. Preclinical Optical Imaging Reagents
        • 9.3.2.2.2. Preclinical Nuclear Imaging Reagents
        • 9.3.2.2.3. Preclinical MRI Contrast Agents
        • 9.3.2.2.4. Preclinical CT Contrast Agents
        • 9.3.2.2.5. Software
    • 9.3.3. Market Attractiveness Analysis: Product Type
  • 9.4. East Asia Preclinical Imaging Market Outlook: Application
    • 9.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 9.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 9.4.2.1. Research and Development
      • 9.4.2.2. Drug Discovery
    • 9.4.3. Market Attractiveness Analysis
  • 9.5. East Asia Preclinical Imaging Market Outlook: End-user
    • 9.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 9.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 9.5.2.1. Pharmaceutical & Biotechnology Companies
      • 9.5.2.2. Academic and research centres
      • 9.5.2.3. Imaging Centres
      • 9.5.2.4. Other End-users
    • 9.5.3. Market Attractiveness Analysis: End-user
  • 9.6. Market Attractiveness Analysis

10. South Asia & Oceania Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 10.1.1. By Country
    • 10.1.2. By Product Type
    • 10.1.3. By Source
    • 10.1.4. By Category
    • 10.1.5. By Distribution Channel
  • 10.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 10.2.1. India
    • 10.2.2. Southeast Asia
    • 10.2.3. ANZ
    • 10.2.4. Rest of South Asia & Oceania
  • 10.3. South Asia & Oceania Preclinical Imaging Market Outlook: Product Type
    • 10.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 10.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 10.3.2.1. Imaging Systems
        • 10.3.2.1.1. Optical Imaging Systems
        • 10.3.2.1.2. Nuclear Imaging Systems
        • 10.3.2.1.3. Micro MRI Systems
        • 10.3.2.1.4. Micro Ultrasound Systems
        • 10.3.2.1.5. Micro CT Systems
        • 10.3.2.1.6. Photoacoustic Imaging Systems
        • 10.3.2.1.7. Magnetic Particle Imaging Systems
      • 10.3.2.2. Reagents
        • 10.3.2.2.1. Preclinical Optical Imaging Reagents
        • 10.3.2.2.2. Preclinical Nuclear Imaging Reagents
        • 10.3.2.2.3. Preclinical MRI Contrast Agents
        • 10.3.2.2.4. Preclinical CT Contrast Agents
        • 10.3.2.2.5. Software
  • 10.4. South Asia & Oceania Preclinical Imaging Market Outlook: Application
    • 10.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 10.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 10.4.2.1. Research and Development
      • 10.4.2.2. Drug Discovery
  • 10.5. South Asia & Oceania Preclinical Imaging Market Outlook: End-user
    • 10.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 10.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 10.5.2.1. Pharmaceutical & Biotechnology Companies
      • 10.5.2.2. Academic and research centres
      • 10.5.2.3. Imaging Centres
      • 10.5.2.4. Other End-users
  • 10.6. Market Attractiveness Analysis

11. Latin America Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 11.1.1. By Country
    • 11.1.2. By Product Type
    • 11.1.3. By Application
    • 11.1.4. By End-user
  • 11.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 11.2.1. Brazil
    • 11.2.2. Mexico
  • 11.3. Latin America Preclinical Imaging Market Outlook: Product Type
    • 11.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 11.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 11.3.2.1. Imaging Systems
        • 11.3.2.1.1. Optical Imaging Systems
        • 11.3.2.1.2. Nuclear Imaging Systems
        • 11.3.2.1.3. Micro MRI Systems
        • 11.3.2.1.4. Micro Ultrasound Systems
        • 11.3.2.1.5. Micro CT Systems
        • 11.3.2.1.6. Photoacoustic Imaging Systems
        • 11.3.2.1.7. Magnetic Particle Imaging Systems
      • 11.3.2.2. Reagents
        • 11.3.2.2.1. Preclinical Optical Imaging Reagents
        • 11.3.2.2.2. Preclinical Nuclear Imaging Reagents
        • 11.3.2.2.3. Preclinical MRI Contrast Agents
        • 11.3.2.2.4. Preclinical CT Contrast Agents
        • 11.3.2.2.5. Software
  • 11.4. Latin America Preclinical Imaging Market Outlook: Application
    • 11.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 11.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 11.4.2.1. Research and Development
      • 11.4.2.2. Drug Discovery
  • 11.5. Latin America Preclinical Imaging Market Outlook: End-user
    • 11.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 11.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 11.5.2.1. Pharmaceutical & Biotechnology Companies
      • 11.5.2.2. Academic and research centres
      • 11.5.2.3. Imaging Centres
      • 11.5.2.4. Other End-users
  • 11.6. Market Attractiveness Analysis

12. Middle East & Africa Preclinical Imaging Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 12.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 12.1.1. By Country
    • 12.1.2. By Product Type
    • 12.1.3. By Application
    • 12.1.4. By End-user
  • 12.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 12.2.1. GCC
    • 12.2.2. South Africa
    • 12.2.3. Northern Africa
  • 12.3. Middle East & Africa Preclinical Imaging Market Outlook: Product Type
    • 12.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 12.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 12.3.2.1. Imaging Systems
        • 12.3.2.1.1. Optical Imaging Systems
        • 12.3.2.1.2. Nuclear Imaging Systems
        • 12.3.2.1.3. Micro MRI Systems
        • 12.3.2.1.4. Micro Ultrasound Systems
        • 12.3.2.1.5. Micro CT Systems
        • 12.3.2.1.6. Photoacoustic Imaging Systems
        • 12.3.2.1.7. Magnetic Particle Imaging Systems
      • 12.3.2.2. Reagents
        • 12.3.2.2.1. Preclinical Optical Imaging Reagents
        • 12.3.2.2.2. Preclinical Nuclear Imaging Reagents
        • 12.3.2.2.3. Preclinical MRI Contrast Agents
        • 12.3.2.2.4. Preclinical CT Contrast Agents
        • 12.3.2.2.5. Software
  • 12.4. Middle East & Africa Preclinical Imaging Market Outlook: Application
    • 12.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
    • 12.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
      • 12.4.2.1. Research and Development
      • 12.4.2.2. Drug Discovery
  • 12.5. Middle East & Africa Preclinical Imaging Market Outlook: End-user
    • 12.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
    • 12.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
      • 12.5.2.1. Pharmaceutical & Biotechnology Companies
      • 12.5.2.2. Academic and research centres
      • 12.5.2.3. Imaging Centres
      • 12.5.2.4. Other End-users
  • 12.6. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
    • 13.2.3. Tier Structure Analysis
    • 13.2.4. Regional Presence Analysis
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Bruker Corporation
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Siemens A.G.
    • 13.3.3. General Electric (GE)
    • 13.3.4. TriFoil Imaging
    • 13.3.5. PerkinElmer, Inc.
    • 13.3.6. VisualSonics Inc.(Fujifilm)
    • 13.3.7. Mediso Ltd.
    • 13.3.8. Agilent Technologies
    • 13.3.9. MILabs B.V.
    • 13.3.10. MR Solutions
    • 13.3.11. Molecubes

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations